RankingsPricing
  1. US-listed companies
  2. Elevance Health, Inc.
  3. Financials
  4. Cash from investing

Elevance Health, Inc.ELV

Market cap
$81.1B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-5,167+13.31%
Dec 31, 2022-4,560-52.69%
Dec 31, 2021-9,638+31.59%
Dec 31, 2020-7,324+162.32%
Dec 31, 2019-2,792+121.76%
Dec 31, 2018-1,259-75.23%
Dec 31, 2017-5,082+888.99%
Dec 31, 2016-514-55.37%
Dec 31, 2015-1,151+18.11%
Dec 31, 2014-975-56.37%
Dec 31, 2013-2,234+137.20%
Dec 31, 2011-942-25.91%
Dec 31, 2010-1,271

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)